FDAnews
www.fdanews.com/articles/124317-fda-ranbaxy-rsquo-s-corrective-actions-have-been-inadequate

FDA: Ranbaxy’s Corrective Actions Have Been Inadequate

February 5, 2010
US Food and Drug Administration (FDA) has said Ranbaxy is not taking adequate corrective measures to meet regulatory requirements even after receiving warning letters from it.
The Times of India